4Dmedical Historical Cash Flow

4DX Stock

0.46 0.01 2.22%

Analysis of 4Dmedical cash flow over time is an excellent tool to project 4Dmedical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 1.3 M or Depreciation of 4.3 M as it is a great indicator of 4Dmedical ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining 4Dmedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 4Dmedical is a good buy for the upcoming year.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4Dmedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About 4Dmedical Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in 4Dmedical balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which 4Dmedical's non-liquid assets can be easily converted into cash.

4Dmedical Cash Flow Chart

At this time, 4Dmedical's Change To Inventory is comparatively stable compared to the past year. Change In Working Capital is likely to gain to about 1.3 M in 2024, despite the fact that Other Cashflows From Financing Activities is likely to grow to (2.9 M).

Other Cashflows From Financing Activities Capital Expenditures Net Income End Period Cash Flow Begin Period Cash Flow Stock Based Compensation

Capital Expenditures

Capital Expenditures are funds used by 4Dmedical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of 4Dmedical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in 4Dmedical financial statement analysis. It represents the amount of money remaining after all of 4Dmedical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most accounts from 4Dmedical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into 4Dmedical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4Dmedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

4Dmedical cash flow statement Correlations

	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Depreciation	Other Non Cash Items	Capital Expenditures	Change To Account Receivables	Net Income	End Period Cash Flow	Begin Period Cash Flow	Sale Purchase Of Stock	Net Borrowings	Stock Based Compensation	Change To Operating Activities	Change To Netincome	Change To Liabilities	Investments	Issuance Of Capital Stock
Change To Inventory		-0.25	-0.02	-0.06	0.15	0.23	-0.17	0.35	-0.09	-0.25	0.0	-0.07	0.4	0.47	0.08	0.43	0.03	-0.34	0.03
Change In Cash	-0.25		0.34	0.64	-0.46	0.17	-0.11	0.43	0.21	0.36	-0.54	-0.23	0.06	-0.02	0.33	0.04	-0.13	0.61	0.53
Free Cash Flow	-0.02	0.34		-0.19	-0.91	-0.07	-0.41	0.6	0.96	-0.72	-0.95	0.77	0.18	-0.02	0.85	-0.11	-0.7	0.71	0.93
Change In Working Capital	-0.06	0.64	-0.19		0.23	0.44	-0.21	0.17	-0.42	0.54	-0.05	-0.6	0.26	0.36	-0.27	0.4	0.54	-0.01	-0.04
Depreciation	0.15	-0.46	-0.91	0.23		0.0	0.06	-0.49	-0.9	0.52	0.89	-0.69	-0.18	0.15	-0.92	0.12	0.88	-0.89	-0.91
Other Non Cash Items	0.23	0.17	-0.07	0.44	0.0		0.19	0.13	-0.3	0.08	-0.07	-0.19	0.92	0.81	0.21	0.97	0.01	0.11	0.08
Capital Expenditures	-0.17	-0.11	-0.41	-0.21	0.06	0.19		-0.38	-0.31	0.35	0.39	-0.14	0.06	-0.28	-0.01	0.08	-0.32	0.14	-0.28
Change To Account Receivables	0.35	0.43	0.6	0.17	-0.49	0.13	-0.38		0.48	-0.45	-0.76	0.27	0.32	0.31	0.65	0.16	-0.27	0.2	0.78
Net Income	-0.09	0.21	0.96	-0.42	-0.9	-0.3	-0.31	0.48		-0.74	-0.85	0.84	-0.04	-0.25	0.81	-0.35	-0.76	0.68	0.85
End Period Cash Flow	-0.25	0.36	-0.72	0.54	0.52	0.08	0.35	-0.45	-0.74		0.59	-0.9	-0.27	-0.12	-0.64	0.02	0.53	-0.19	-0.58
Begin Period Cash Flow	0.0	-0.54	-0.95	-0.05	0.89	-0.07	0.39	-0.76	-0.85	0.59		-0.62	-0.29	-0.09	-0.86	-0.01	0.62	-0.71	-0.98
Sale Purchase Of Stock	-0.07	-0.23	0.77	-0.6	-0.69	-0.19	-0.14	0.27	0.84	-0.9	-0.62		0.13	-0.19	0.7	-0.21	-0.72	0.47	0.61
Net Borrowings	0.4	0.06	0.18	0.26	-0.18	0.92	0.06	0.32	-0.04	-0.27	-0.29	0.13		0.79	0.43	0.93	-0.19	0.17	0.29
Stock Based Compensation	0.47	-0.02	-0.02	0.36	0.15	0.81	-0.28	0.31	-0.25	-0.12	-0.09	-0.19	0.79		0.1	0.87	0.26	-0.24	0.06
Change To Operating Activities	0.08	0.33	0.85	-0.27	-0.92	0.21	-0.01	0.65	0.81	-0.64	-0.86	0.7	0.43	0.1		0.14	-0.86	0.73	0.92
Change To Netincome	0.43	0.04	-0.11	0.4	0.12	0.97	0.08	0.16	-0.35	0.02	-0.01	-0.21	0.93	0.87	0.14		0.1	-0.06	0.02
Change To Liabilities	0.03	-0.13	-0.7	0.54	0.88	0.01	-0.32	-0.27	-0.76	0.53	0.62	-0.72	-0.19	0.26	-0.86	0.1		-0.78	-0.69
Investments	-0.34	0.61	0.71	-0.01	-0.89	0.11	0.14	0.2	0.68	-0.19	-0.71	0.47	0.17	-0.24	0.73	-0.06	-0.78		0.72
Issuance Of Capital Stock	0.03	0.53	0.93	-0.04	-0.91	0.08	-0.28	0.78	0.85	-0.58	-0.98	0.61	0.29	0.06	0.92	0.02	-0.69	0.72

Click cells to compare fundamentals

4Dmedical Account Relationship Matchups

4Dmedical cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	612.7K	(137.3K)	(273.1K)	(663.5K)	327.2K	343.6K
Change In Cash	5.3M	72.5M	(29.8M)	18.5M	(39.0M)	(37.0M)
Free Cash Flow	(8.8M)	(15.2M)	(28.3M)	(23.4M)	(31.2M)	(29.6M)
Change In Working Capital	3.0M	4.6M	(2.8M)	4.8M	702.9K	1.3M
Other Cashflows From Financing Activities	17.1M	(2.1M)	(995.5K)	170.6K	(3.1M)	(2.9M)
Depreciation	584.7K	741.5K	1.5M	2.6M	4.1M	4.3M
Other Non Cash Items	9.8M	1.5M	582.1K	1.4M	344.1K	326.9K
Capital Expenditures	1.2M	725.0K	3.1M	731.3K	302.9K	287.7K
Total Cash From Operating Activities	(7.7M)	(14.5M)	(25.3M)	(22.7M)	(30.9M)	(29.3M)
Change To Account Receivables	467.3K	868.0K	(2.0M)	(1.8M)	(444.8K)	(422.6K)
Net Income	(22.0M)	(21.4M)	(24.6M)	(31.5M)	(36.0M)	(34.2M)
Total Cash From Financing Activities	13.8M	87.6M	(995.5K)	42.7M	31.9M	21.3M
End Period Cash Flow	8.4M	80.9M	51.1M	69.6M	30.6M	27.1M
Other Cashflows From Investing Activities	372.0K	144.6K	(422.6K)	(882.4K)	(1.0M)	(967.2K)
Begin Period Cash Flow	3.1M	8.4M	80.9M	51.1M	69.6M	73.1M
Sale Purchase Of Stock	1.2M	(6.4M)	0.0	(2.5M)	(2.3M)	(2.2M)
Net Borrowings	14.1M	(533.7K)	(995.5K)	170.6K	153.5K	145.8K
Stock Based Compensation	3.5M	1.5M	614.0K	1.0M	2.2M	1.6M
Total Cashflows From Investing Activities	(786.4K)	(580.4K)	(3.5M)	(1.6M)	(1.5M)	(1.5M)
Change To Operating Activities	1.0M	39.2K	(372.9K)	(1.7M)	(1.5M)	(1.4M)
Change To Netincome	10.8M	1.5M	582.1K	1.4M	1.7M	2.4M
Change To Liabilities	1.4M	4.6M	(471.3K)	7.4M	8.5M	8.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for 4Dmedical Stock Analysis

When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC